Cormark upgraded shares of Cresco Labs (OTCMKTS:CRLBF – Free Report) from a hold rating to a moderate buy rating in a research note issued to investors on Monday morning,Zacks.com reports. Cormark also issued estimates for Cresco Labs’ FY2025 earnings at ($0.07) EPS and FY2026 earnings at $0.01 EPS.
Separately, Atb Cap Markets lowered shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cresco Labs currently has an average rating of “Buy” and an average price target of $3.00.
Get Our Latest Stock Analysis on Cresco Labs
Cresco Labs Trading Up 1.4 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01). The company had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. On average, research analysts expect that Cresco Labs will post -0.2 EPS for the current year.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Recommended Stories
- Five stocks we like better than Cresco Labs
- Insider Selling Explained: Can it Inform Your Investing Choices?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Short Selling – The Pros and Cons
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.